Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-01

AUTHORS

Sharon L. Hale, Robert A. Kloner

ABSTRACT

The no-reflow phenomenon occurs when an epicardial coronary artery is reopened following myocardial infarction, but portions of the intramural microvasculature fail to reperfuse. One potential mechanism for this is the presence of fibrin tactoids. In addition, some recent studies have suggested that dabigatran treatment may be associated with increased incidence of myocardial infarction. Our aim was to investigate the effect on myocardial infarct size and no-reflow in an acute model of ischemia/reperfusion. Anesthetized, open-chest rabbits were randomly assigned to receive dabigatran (Dab, 0.5 mg/kg bolus + infusion, 0.15 mg/kg/h, IV, n = 11) or vehicle (Veh, n = 11) 15 m before a 30-m coronary artery occlusion and during 2.5 h of the 3 h reperfusion procedure. At the end of the reperfusion period, infarct size (% risk zone) and no-reflow defect were measured. The ischemic risk zone (% of left ventricle) was similar in groups, 24 % in Dab and 25 % in Veh. Necrosis was neither reduced nor increased by Dab treatment; expressed as a percentage of the risk region, infarct size was 30 ± 4 % in Dab and 28 ± 5 % in Veh, p = 0.76. The extent of no-reflow was comparable, expressed either as a percent of the risk region (19 ± 3 %, Dab and 18 ± 3 %, Veh) or as a percent of the necrotic zone (67 ± 8 % Dab and 65 ± 10 % Veh). Dab treatment had no effect on heart rate or blood pressure. Dabigatran treatment did not prevent or ameliorate the no-reflow phenomenon, suggesting that fibrin does not play a major role in the development of microvascular obstruction. Dabigatran did not exacerbate myocardial infarct size. More... »

PAGES

50-54

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-014-1098-x

DOI

http://dx.doi.org/10.1007/s11239-014-1098-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018594080

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25017632


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antithrombins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzimidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dabigatran", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Models, Animal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Reperfusion Injury", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "No-Reflow Phenomenon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rabbits", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta-Alanine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Good Samaritan Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413117.1", 
          "name": [
            "The Heart Institute of Good Samaritan Hospital, 1225 Wilshire Blvd, 90017, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hale", 
        "givenName": "Sharon L.", 
        "id": "sg:person.01354357102.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354357102.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Southern California", 
          "id": "https://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "The Heart Institute of Good Samaritan Hospital, 1225 Wilshire Blvd, 90017, Los Angeles, CA, USA", 
            "Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kloner", 
        "givenName": "Robert A.", 
        "id": "sg:person.01156126366.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156126366.97"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1080/17482940902978061", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004830020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1074248409357742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005680089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1074248409357742", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005680089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2013.03.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008375134"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11239-012-0857-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015980749", 
          "https://doi.org/10.1007/s11239-012-0857-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1538-7836.2007.02526.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019179279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2011.1666", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019677758"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(00)00865-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025236121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.107.742312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027650992"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sap.0b013e31825c089c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032832483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/sap.0b013e31825c089c", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032832483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/shk.0000000000000072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033276158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/shk.0000000000000072", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033276158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.111.055970", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033986445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmjopen-2012-001592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035226968"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2006.08.054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037118428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ccd.23179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037517130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci107898", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037776240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2013.08.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038980507"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000072226", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041602823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0003-4975(02)04691-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044232544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0003-4975(02)04691-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044232544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/heart.87.2.162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046850930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/157016111206141210121441", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069196947"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.19-24-10898.1999", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074561347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075078356", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077078328", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078594471", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1152/ajpheart.1997.273.1.h220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083126862"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-01", 
    "datePublishedReg": "2015-01-01", 
    "description": "The no-reflow phenomenon occurs when an epicardial coronary artery is reopened following myocardial infarction, but portions of the intramural microvasculature fail to reperfuse. One potential mechanism for this is the presence of fibrin tactoids. In addition, some recent studies have suggested that dabigatran treatment may be associated with increased incidence of myocardial infarction. Our aim was to investigate the effect on myocardial infarct size and no-reflow in an acute model of ischemia/reperfusion. Anesthetized, open-chest rabbits were randomly assigned to receive dabigatran (Dab, 0.5\u00a0mg/kg bolus\u00a0+\u00a0infusion, 0.15\u00a0mg/kg/h, IV, n\u00a0=\u00a011) or vehicle (Veh, n\u00a0=\u00a011) 15\u00a0m before a 30-m coronary artery occlusion and during 2.5 h of the 3\u00a0h reperfusion procedure. At the end of the reperfusion period, infarct size (% risk zone) and no-reflow defect were measured. The ischemic risk zone (% of left ventricle) was similar in groups, 24\u00a0% in Dab and 25\u00a0% in Veh. Necrosis was neither reduced nor increased by Dab treatment; expressed as a percentage of the risk region, infarct size was 30\u00a0\u00b1\u00a04\u00a0% in Dab and 28\u00a0\u00b1\u00a05\u00a0% in Veh, p\u00a0=\u00a00.76. The extent of no-reflow was comparable, expressed either as a percent of the risk region (19\u00a0\u00b1\u00a03\u00a0%, Dab and 18\u00a0\u00b1\u00a03\u00a0%, Veh) or as a percent of the necrotic zone (67\u00a0\u00b1\u00a08\u00a0% Dab and 65\u00a0\u00b1\u00a010\u00a0% Veh). Dab treatment had no effect on heart rate or blood pressure. Dabigatran treatment did not prevent or ameliorate the no-reflow phenomenon, suggesting that fibrin does not play a major role in the development of microvascular obstruction. Dabigatran did not exacerbate myocardial infarct size. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-014-1098-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "name": "Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion", 
    "pagination": "50-54", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5897a5c74a3cdef496b49a383342dbb36c3c85eacb3bb7ef719d8b08a21f7104"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25017632"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-014-1098-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018594080"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-014-1098-x", 
      "https://app.dimensions.ai/details/publication/pub.1018594080"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T02:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000521.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-014-1098-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1098-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1098-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1098-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1098-x'


 

This table displays all metadata directly associated to this object as RDF triples.

193 TRIPLES      21 PREDICATES      64 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-014-1098-x schema:about N1aa4c900320341beaaf50e289d8e2aa2
2 N2ef74911e1054c0f83fd312128ebcf46
3 N40ad3e4e91fe46679f4d57ce728d5620
4 N64726dadb1c244b4887d1d1ae794c38a
5 N9ebed3ccba4948899130a5b6eebebd1c
6 Nd65d2429b4ed4fd4aee7d4ea12825a2d
7 Nddcf68a723774a4cb45eaf2fc81cf6aa
8 Nf17bdd8c57f84af48c0ff9e2a3fabeb9
9 Nf96788ae79f14b26a91c6cecc2f458f7
10 Nff718e4cbd6646589e78631c3873e32b
11 anzsrc-for:11
12 anzsrc-for:1102
13 schema:author Nf7e8c54cd3a244b19d7e73914c7fe4b3
14 schema:citation sg:pub.10.1007/s11239-012-0857-9
15 https://app.dimensions.ai/details/publication/pub.1075078356
16 https://app.dimensions.ai/details/publication/pub.1077078328
17 https://app.dimensions.ai/details/publication/pub.1078594471
18 https://doi.org/10.1001/archinternmed.2011.1666
19 https://doi.org/10.1002/ccd.23179
20 https://doi.org/10.1016/j.amjcard.2006.08.054
21 https://doi.org/10.1016/j.amjcard.2013.08.027
22 https://doi.org/10.1016/j.jacc.2013.03.020
23 https://doi.org/10.1016/s0003-4975(02)04691-x
24 https://doi.org/10.1016/s0735-1097(00)00865-2
25 https://doi.org/10.1080/17482940902978061
26 https://doi.org/10.1097/sap.0b013e31825c089c
27 https://doi.org/10.1097/shk.0000000000000072
28 https://doi.org/10.1111/j.1538-7836.2007.02526.x
29 https://doi.org/10.1136/bmjopen-2012-001592
30 https://doi.org/10.1136/heart.87.2.162
31 https://doi.org/10.1152/ajpheart.1997.273.1.h220
32 https://doi.org/10.1159/000072226
33 https://doi.org/10.1161/circulationaha.107.742312
34 https://doi.org/10.1161/circulationaha.111.055970
35 https://doi.org/10.1172/jci107898
36 https://doi.org/10.1177/1074248409357742
37 https://doi.org/10.1523/jneurosci.19-24-10898.1999
38 https://doi.org/10.2174/157016111206141210121441
39 schema:datePublished 2015-01
40 schema:datePublishedReg 2015-01-01
41 schema:description The no-reflow phenomenon occurs when an epicardial coronary artery is reopened following myocardial infarction, but portions of the intramural microvasculature fail to reperfuse. One potential mechanism for this is the presence of fibrin tactoids. In addition, some recent studies have suggested that dabigatran treatment may be associated with increased incidence of myocardial infarction. Our aim was to investigate the effect on myocardial infarct size and no-reflow in an acute model of ischemia/reperfusion. Anesthetized, open-chest rabbits were randomly assigned to receive dabigatran (Dab, 0.5 mg/kg bolus + infusion, 0.15 mg/kg/h, IV, n = 11) or vehicle (Veh, n = 11) 15 m before a 30-m coronary artery occlusion and during 2.5 h of the 3 h reperfusion procedure. At the end of the reperfusion period, infarct size (% risk zone) and no-reflow defect were measured. The ischemic risk zone (% of left ventricle) was similar in groups, 24 % in Dab and 25 % in Veh. Necrosis was neither reduced nor increased by Dab treatment; expressed as a percentage of the risk region, infarct size was 30 ± 4 % in Dab and 28 ± 5 % in Veh, p = 0.76. The extent of no-reflow was comparable, expressed either as a percent of the risk region (19 ± 3 %, Dab and 18 ± 3 %, Veh) or as a percent of the necrotic zone (67 ± 8 % Dab and 65 ± 10 % Veh). Dab treatment had no effect on heart rate or blood pressure. Dabigatran treatment did not prevent or ameliorate the no-reflow phenomenon, suggesting that fibrin does not play a major role in the development of microvascular obstruction. Dabigatran did not exacerbate myocardial infarct size.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N3736aa1a65784907a4d1bbd4156c62cd
46 Nd38689b480cf41cd992d68c05df0e7a4
47 sg:journal.1113719
48 schema:name Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion
49 schema:pagination 50-54
50 schema:productId N3bc5ffa2d68d43619733a5ce00c764ed
51 N7df72abdd4454962928af888eff07873
52 Naff80b63f5bc49768cf32008230261a5
53 Nb21f59a5edb44ae4b8a8421b250b2232
54 Nce9bf19bc790401e89e90274c2b661c4
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018594080
56 https://doi.org/10.1007/s11239-014-1098-x
57 schema:sdDatePublished 2019-04-11T02:07
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher Ncb18e23c61634587b2a25a3bb98f9740
60 schema:url http://link.springer.com/10.1007%2Fs11239-014-1098-x
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N1aa4c900320341beaaf50e289d8e2aa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Rabbits
66 rdf:type schema:DefinedTerm
67 N25e8b581d7114e7aacbef02df0bae3f4 rdf:first sg:person.01156126366.97
68 rdf:rest rdf:nil
69 N2ef74911e1054c0f83fd312128ebcf46 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Dabigatran
71 rdf:type schema:DefinedTerm
72 N3736aa1a65784907a4d1bbd4156c62cd schema:volumeNumber 39
73 rdf:type schema:PublicationVolume
74 N3bc5ffa2d68d43619733a5ce00c764ed schema:name nlm_unique_id
75 schema:value 9502018
76 rdf:type schema:PropertyValue
77 N40ad3e4e91fe46679f4d57ce728d5620 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Animals
79 rdf:type schema:DefinedTerm
80 N64726dadb1c244b4887d1d1ae794c38a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Benzimidazoles
82 rdf:type schema:DefinedTerm
83 N7df72abdd4454962928af888eff07873 schema:name pubmed_id
84 schema:value 25017632
85 rdf:type schema:PropertyValue
86 N9ebed3ccba4948899130a5b6eebebd1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Antithrombins
88 rdf:type schema:DefinedTerm
89 Naff80b63f5bc49768cf32008230261a5 schema:name dimensions_id
90 schema:value pub.1018594080
91 rdf:type schema:PropertyValue
92 Nb21f59a5edb44ae4b8a8421b250b2232 schema:name doi
93 schema:value 10.1007/s11239-014-1098-x
94 rdf:type schema:PropertyValue
95 Ncb18e23c61634587b2a25a3bb98f9740 schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 Nce9bf19bc790401e89e90274c2b661c4 schema:name readcube_id
98 schema:value 5897a5c74a3cdef496b49a383342dbb36c3c85eacb3bb7ef719d8b08a21f7104
99 rdf:type schema:PropertyValue
100 Nd38689b480cf41cd992d68c05df0e7a4 schema:issueNumber 1
101 rdf:type schema:PublicationIssue
102 Nd65d2429b4ed4fd4aee7d4ea12825a2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Disease Models, Animal
104 rdf:type schema:DefinedTerm
105 Nddcf68a723774a4cb45eaf2fc81cf6aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Myocardial Reperfusion Injury
107 rdf:type schema:DefinedTerm
108 Nf17bdd8c57f84af48c0ff9e2a3fabeb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name No-Reflow Phenomenon
110 rdf:type schema:DefinedTerm
111 Nf7e8c54cd3a244b19d7e73914c7fe4b3 rdf:first sg:person.01354357102.82
112 rdf:rest N25e8b581d7114e7aacbef02df0bae3f4
113 Nf96788ae79f14b26a91c6cecc2f458f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Male
115 rdf:type schema:DefinedTerm
116 Nff718e4cbd6646589e78631c3873e32b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name beta-Alanine
118 rdf:type schema:DefinedTerm
119 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
120 schema:name Medical and Health Sciences
121 rdf:type schema:DefinedTerm
122 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
123 schema:name Cardiorespiratory Medicine and Haematology
124 rdf:type schema:DefinedTerm
125 sg:journal.1113719 schema:issn 0929-5305
126 1573-742X
127 schema:name Journal of Thrombosis and Thrombolysis
128 rdf:type schema:Periodical
129 sg:person.01156126366.97 schema:affiliation https://www.grid.ac/institutes/grid.42505.36
130 schema:familyName Kloner
131 schema:givenName Robert A.
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156126366.97
133 rdf:type schema:Person
134 sg:person.01354357102.82 schema:affiliation https://www.grid.ac/institutes/grid.413117.1
135 schema:familyName Hale
136 schema:givenName Sharon L.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354357102.82
138 rdf:type schema:Person
139 sg:pub.10.1007/s11239-012-0857-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015980749
140 https://doi.org/10.1007/s11239-012-0857-9
141 rdf:type schema:CreativeWork
142 https://app.dimensions.ai/details/publication/pub.1075078356 schema:CreativeWork
143 https://app.dimensions.ai/details/publication/pub.1077078328 schema:CreativeWork
144 https://app.dimensions.ai/details/publication/pub.1078594471 schema:CreativeWork
145 https://doi.org/10.1001/archinternmed.2011.1666 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019677758
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1002/ccd.23179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037517130
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.amjcard.2006.08.054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037118428
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.amjcard.2013.08.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038980507
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.jacc.2013.03.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008375134
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/s0003-4975(02)04691-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044232544
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/s0735-1097(00)00865-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025236121
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1080/17482940902978061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004830020
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1097/sap.0b013e31825c089c schema:sameAs https://app.dimensions.ai/details/publication/pub.1032832483
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1097/shk.0000000000000072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033276158
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1111/j.1538-7836.2007.02526.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1019179279
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1136/bmjopen-2012-001592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035226968
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1136/heart.87.2.162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046850930
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1152/ajpheart.1997.273.1.h220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083126862
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1159/000072226 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041602823
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1161/circulationaha.107.742312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027650992
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1161/circulationaha.111.055970 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033986445
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1172/jci107898 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037776240
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1177/1074248409357742 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005680089
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1523/jneurosci.19-24-10898.1999 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074561347
184 rdf:type schema:CreativeWork
185 https://doi.org/10.2174/157016111206141210121441 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069196947
186 rdf:type schema:CreativeWork
187 https://www.grid.ac/institutes/grid.413117.1 schema:alternateName Good Samaritan Hospital
188 schema:name The Heart Institute of Good Samaritan Hospital, 1225 Wilshire Blvd, 90017, Los Angeles, CA, USA
189 rdf:type schema:Organization
190 https://www.grid.ac/institutes/grid.42505.36 schema:alternateName University of Southern California
191 schema:name Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
192 The Heart Institute of Good Samaritan Hospital, 1225 Wilshire Blvd, 90017, Los Angeles, CA, USA
193 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...